004310.KS
Hyundai Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,680.00
−2.91%Margins
Gross margin
35.6%
EBITDA margin
5.0%
EBIT margin
2.6%
Net margin
1.7%
FCF margin
3.3%
2.8%
Return on equity
1.6%
Return on assets
3.0%
Return on invested capital
0.92x
Asset turnover
KRW 10.3B
Cash from operations
KRW 867
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Aug 1, 2026